T/CACM 1376-2022 Active Group standards

T/CACM 1376-2022 Guidelines for Traditional Chinese Medicine in the Treatment ofidiopathic membranous nephropathy

T/CACM 1376-2022 Guidelines for Traditional Chinese Medicine in the Treatment ofidiopathic membranous nephropathy

Publish Date: 2021-12-21 Implement Date: 2021-12-21 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 1376-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2021-12-21
Implement Date: 2021-12-21

Scope

Scope: This document specifies the risk assessment, traditional Chinese medicine (TCM) syndrome differentiation, and treatment recommendations for adult idiopathic membranous nephropathy. This document is applicable to all levels of TCM (integrated TCM and Western medicine) medical institutions and medical institutions offering TCM services, and can be used by licensed TCM practitioners (integrated TCM and Western medicine), licensed assistant TCM practitioners, policy makers, etc. Main technical content: Preface Introduction 1 Scope 2 Normative referenced documents 3 Terms and definitions 4 Evidence quality evaluation and recommendation explanation 5 Disease progression risk factors and renal function loss progression risk assessment 6 Syndrome differentiation 7 Western medicine treatment 8 Recommendations for TCM treatment Appendix A (informative) Evidence quality grading and recommendation strength Appendix B (informative) Preparation notes for this document References

Development Information

Related Standards

Contact Us